News
Adrian was just nine months old when he had his first life-threatening allergic reaction. For Adrian’s family, the ongoing risk of accidental exposure and cross-contamination led them to take part in a clinical trial designed to desensitise children with peanut allergy.
Highlighting the recent success of their researchers and partner institutes who have been awarded over $16.15 million in research grants.
The report, A Rare Kind of Care, examines the current landscape of rare disease policy in Australia, aimed at ensuring all living with a rare disease experience health equity.
A world-first clinical trial using a novel liquid biopsy has transformed the lives of children and young people with arteriovenous malformations (AVMs).
Kids Research showcased the power of collaboration at the Kids Advanced Therapeutics Symposium bringing together healthcare providers, researchers, industry leaders, community partners and families.